Which of the following do you prefer
AOD-9604 (Anti-Obesity Drug 9604) is a modified peptide fragment consisting of the terminal 15 amino acids of human growth hormone (positions 176-191) with a tyrosine residue added at the N-terminus for stability
Referenced Studies Only trained personnel should handle this compound
We also provide day-to-day maintenance works, both planned and reactive, to better serve our clients on-site employees and customers.
When to Expect Results Based on research and anecdotal reports: Week 1-2: Increased energy and better sleep quality Week 3-4: Noticeable reduction in abdominal fat, improved muscle definition Week 6-8: Significant fat loss, better insulin sensitivity (if measured) Week 8-12: Maximum effects plateau, consider cycling off Cycling Recommendations Most protocols recommend: 8 to 12 weeks on 4 to 8 weeks off Reassess and repeat if needed Cycling allows your body to maintain sensitivity to the compound and prevents potential long-term adaptations
3-Adrenergic Receptor Modulation Both hGH and AOD9604 increase 3-adrenergic receptor (3-AR) expression in adipose tissue importantly, restoring repressed 3-AR RNA levels in obese mice to levels comparable with those in lean mice